Access cutting-edge anemia treatment through this clinical trial at a research site in Long Island City. Study-provided care at no cost to qualified participants.
Access anemia specialists in Long Island City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related anemia treatment provided free
This purpose of this study is to establish proof of concept of tebapivat in participants with LR-MDS in Phase 2a and to evaluate the effect of tebapivat on transfusion independence (TI) in participants with LR-MDS in phase 2b.
Sponsor: Agios Pharmaceuticals, Inc.
Check if you qualify for this anemia clinical trial in Long Island City, NY
If you're searching for anemia treatment options in Long Island City, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Long Island City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.